30
CARDIOVASCULAR
hamburger

With a commitment to advancing innovative technology to ensure people living with structural heart diseases have safe and effective treatment options, Abbott was the first to develop minimally invasive transcatheter treatment options for patients with mitral regurgitation (MR) and tricuspid regurgitation (TR), and reimagined the minimally invasive treatment of aortic stenosis.

MitraClip™ TMVr System

MitraClip™ Transcatheter Mitral Valve repair (TMVr) procedure is a minimally invasive treatment option, uniquely designed for the mitral valve, for select patients with primary or secondary MR. As the first TMVr therapy recommended by AHA/ACC, ESC/EACTS and APSC Guidelines, MitraClip is the only tailored therapy with over 17+ years of clinical experience and more than 100,000 patients treated worldwide, allowing physicians to treat more patients with more options.

Navitor™ TAVI System

Advancing the forefront of innovative design, the Navitor™ Transcatheter Aortic Valve Implantation (TAVI) System brings together smart PVL-sealing technology, exceptional single-digit gradients,1 stable deployment, accurate valve placement and uncompromised coronary access to achieve excellent clinical outcomes.

Portico™ with FlexNav™ TAVI System

Portico™ with FlexNav™ Transcatheter Aortic Valve Implantation (TAVI) System offers patients with aortic stenosis a minimally invasive treatment option. The Portico™ valve is the first fully resheathable,* repositionable,* and retrievable* valve, while the FlexNav™ delivery system offers remarkable deliverability and exceptionally smooth tracking to treat every TAVI case.2-4

*Until fully deployed

Tendyne™ TMVR System

Tendyne™ Transcatheter Mitral Valve Replacement (TMVR) System is first-in-class technology that offers select patients with MR, who are at high risk for surgery, a minimally invasive option for mitral valve replacement. Tendyne TMVI system provides symptom relief and quality of life improvement by safely and effectively reducing MR.

TriClip™ TTVr System

TriClip™ Transcatheter Tricuspid Valve Repair (TTVr) is a minimally invasive treatment option for patients with symptomatic severe Tricuspid Regurgitation (TR). TriClip TTVr offers unmatched stability, precision, and control for the unique challenges of the tricuspid anatomy to achieve sustained, clinically significant improvements in the lives of TR patients.

  • Manuals & Technical Resources
  • Cardiovascular Products
  • Customer Service

References

  1. Abbott data on file CL1014440.
  2. Portico Transfemoral Transcatheter Aortic Valve Implantation System Instructions for Use.
  3. Abbott data on file 90158807.
  4. Abbott data on file. Portico Transcatheter Aortic Valve Implantation System CE Mark 585003.

MAT-2011954 v4.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.